Search Results 1061-1070 of 13928 for Assay

1. A Study Of The Effect Of Dalcetrapib On Cardiovascular Risk For A Genetically Defined Population Who Have Had A Recent Acute Coronary Syndrome Event - Mayo Clinic

   AA genotype at variant gene as determined by Genotype Assay testing, conducted at a designated investigational testing site (ITS); Clinically stable, ie ...

2. Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma - Mayo Clinic

   Tumor PD-L1 expression defined as a CPS ≥ 1 using the FDA- approved pembrolizumab (KEYTRUDA®) assay (local testing). No prior systemic anticancer therapy ...

3. Kidney Tumors Clinical Trials - Mayo Clinic Research

   GRAIL is using deep sequencing of circulating cell-free nucleic acids (cfNAs) to develop assays to detect cancer early in blood. The purpose of this study ...

4. A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants With Normal and Impaired Renal Function - Mayo Clinic

   Serum free light chain assay: Involved free light chain level ≥ 10 milligrams per deciliter (mg/dL) (≥ 100 milligrams per liter [mg/L]) and an abnormal ...

5. Small Lymphocytic Lymphoma Clinical Trials - Mayo Clinic Research

   TP-0903 has shown potent inhibition of AXL kinase and other TAM family members in a biochemical kinase assay. ... assays to detect cancer early in blood.

6. Type 1 Diabetes Clinical Trials - Mayo Clinic Research

   ... assay that would detect antibodies to insulin and insulin analogs. Butyrate Adjuvant Therapy for Type 1 Diabetes Rochester, MN. This study will test the ...

7. Safety Study Of OA-235i In Subjects With Nonalcoholic Steatohepatitis - Mayo Clinic

   ... assays in adult subjects with suspected or confirmed diagnosis of noncirrhotic NASH with no fibrosis to moderate fibrosis (stages F0-F2) and correlate PD ...

8. A Study To Evaluate Efficacy And Safety Of An Investigational Drug Named Volixibat In Patients With Itching Caused By Primary Biliary Cholangitis - Mayo Clinic

   ... on UDCA therapy);; Documented positive AMA titer (> 1:40 titer on immunofluorescence or M2 positive by enzyme-linked immunosorbent assay) or PBC-specific ANA ...

9. Study To Evaluate The Efficacy And Safety Of Tak-861 For The Treatment Of Narcolepsy With Cataplexy - Mayo Clinic

   ... assay]. Exclusion Criteria: The participant has a current medical disorder, other than narcolepsy with cataplexy, associated with EDS. The participant: (a) ...

10. Medical Laboratory Science Program (Florida and Minnesota)

    Professional skills. Perform a wide variety of laboratory tests from low to high complexity; Troubleshoot laboratory assays, identifying and correcting ...